Watch AVLN. Know when insiders buy.
One email the day a filing lands. Free.
AVLN
Avalyn Pharma Inc.
30.28
−0.31 −1.01%
USD · close Nov 13
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
47
WATCH · insiders 25, shorts 68
Insiders, 90 days
−$6.7M
net selling · 0 buys, 4 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 23.33 – 39.25
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$31.3M | −$28.9M | — | -0.98 | −$26.1M | $269K | −$26.3M | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$27.9M | −$26.9M | — | -21.83 | −$29.9M | $318K | −$30.2M | Aug 12 |
| Q2 2025 · Jun 30 | — | — | — | −$21.8M | −$20.2M | — | -17.63 | −$20.7M | $0 | −$20.7M | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$18.7M | −$17.5M | — | -63.24 | −$19.3M | $8K | −$19.3M | Aug 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Avalyn Pharma Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.